Clinical trial
Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2
NCT01867788 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2012
- Completion date
- September 30, 2017
- Enrollment
- 76 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease